APP and Alzheimer disease: Light activation of Channelrhodopsin-2 (ChR2)-expressing cortical pyramidal neurons at the normal frequency of slow oscillations, 0.6 Hz, restores slow oscillation power (Fig. 1A 1X Rx) and halts the progression of AD pathophysiology in APP mice2.